Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016064 |
---|---|
Receipt number | R000018669 |
Scientific Title | Phase 2 study of the treatment discontinuation after the change from 2nd tyrosine kinase inhibitors to Interferon-alpha in chronoic myeloid leukemia patients who maintained molecular remission. |
Date of disclosure of the study information | 2015/01/05 |
Last modified on | 2017/12/28 09:04:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/26 14:12:38 | ||
2 | Update | 2015/06/27 23:36:26 | Email |
|
3 | Update | 2017/12/28 09:04:04 | Recruitment status |